The efficacy and safety of annulus fibrosus suture as adjuvant therapy for lumbar disc herniation: a systematic review and meta-analysis

纤维环缝合术作为腰椎间盘突出症辅助治疗的疗效和安全性:系统评价和荟萃分析

阅读:1

Abstract

OBJECTIVE: Lumbar disc herniation (LDH) has demonstrated a rising prevalence in contemporary clinical practice, significantly compromising patients' daily lives and potentially necessitating surgical intervention. While annulus fibrosus suture (AFS) techniques are increasingly incorporated into surgical protocols, current evidence remains inconclusive regarding their definitive clinical advantages. METHODS: We performed a comprehensive search of eight databases from inception to September 2025 to identify published articles on AFS for LDH. Outcome measures encompassed operative time, incision length, blood loss, length of stay (LOS), visual analog scale (VAS) score, Japanese Orthopedic Association (JOA) score, Oswestry disability index (ODI) score, disc height, recurrence, and complication. The quality of the studies was analyzed using the RoB-2 and ROBINS-I tools. Statistical analyses were performed using RevMan 5.4 software and Stata 17 software. The GRADE approach was used to evaluate the certainty of evidence for outcomes. RESULTS: A total of 58 studies encompassing 5,765 patients diagnosed with LDH. The control group had shorter operative time (MD = 4.85, 95% CI: 2.79 to 6.92, P < 0.00001) compared to the AFS group. There were no differences in terms of incision length, blood loss, LOS, JOA score, ODI score, and complication between the techniques. AFS group demonstrated a significant benefit over control group in terms of VAS score (MD = -0.24, 95% CI: -0.33 to -0.14, P < 0.00001), disc height (SMD = 1.36, 95% CI: 0.73 to 2.00, P < 0.0001), and recurrence (RR = 0.34, 95% CI: 0.27 to 0.42, P < 0.00001). The results of subgroup analysis showed that different study types and different follow-up times were a source of heterogeneity. The quality of evidence for outcome measures ranges from very low to moderate. CONCLUSION: Current evidence suggests that AFS therapy may be advantageous in improving clinical symptoms and may reduce postoperative recurrence. Due to limited data and low quality of evidence, additional large-scale, multicenter trials are needed to verify and strengthen these findings.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。